European Archives - Page 601 of 1472 - European Medical Journal

MHRA signs off on Astellas' gastric cancer treatment

Astellas Pharma has received approval from the UK’s MHRA for its innovative therapy designed to treat gastric cancer.

Recent Advancements in wAIHA

AIHA is an acquired, heterogeneous group of rare diseases with a prevalence of 17 per 100,000.1 This group includes wAIHA…

Lower Risk of Colorectal Cancer with Aspirin Use in People with Unhealthy Lifestyles

Research highlights that aspirin use is associated with a significant reduction in colorectal cancer incidence, particularly among individuals with less healthy lifestyle habits.

New Biomarkers Predict Disease Activity in Juvenile Arthritis

Researchers have identified two new potential biomarkers, which could be crucial in predicting disease activity in children with non-systemic juvenile idiopathic arthritis.

EMJ Hematology 12 [Supplement 3] 2024

Find out more about the current management and patient experience of warm autoimmune haemolytic anaemia (wAIHA)…

FDA nod for world's first needle-free allergic reaction treatment

The FDA has granted approval for an innovative epinephrine nasal spray, making it the first needle-free emergency treatment for potentially fatal allergic reactions.

Upgrading the US congress customer experience

A US congress is the place to put your drug on the map, but is this landscape the home of great customer experience for HCPs?

Astellas’ Tadaaki Taniguchi on how to challenge the status quo

In this season finale of the podcast, Isabel speaks to Dr Tadaaki Taniguchi, Chief Medical Officer, Head of Medical and Development, Astellas Pharma.

Stress Diminishes Cognitive Reserve's Protective Role in Dementia

Recent research from the Karolinska Institutet in Stockholm has shed light on the complex relationship between cognitive reserve and stress.

Myotonia: Are We Underestimating the Burden in Myotonic Disorders?

‘Raising awareness of the burden of disease due to myotonia will enhance understanding of patients’ needs, and improve the management…